RXi Pharmaceuticals Corp. (RXII)

$2.13 -0.11 (-4.91%)

11/27/2009 12:59 PM

CAPS Rating

Open

$2.15

Previous Close

$2.24

Daily Range

$2.11 - $2.20

52-Week Range

$1.51 - $9.50

Market Cap

$34.52M

P/E Ratio

0.00

Dividend (Yield)

N/A (N/A)

Volume

51,302

Average Daily Volume

117,000

RXII VS S&P 500 (SPY)

Caps

Motley Fool CAPS is a community working together to find better stocks and to become better investors.

This Big Winner Has Hit Its Prime16 hours ago – The Motley Fool
Dream Stocks for Biotech InvestorsNovember 25, 2009 – The Motley Fool
Still Enjoying Those Acquisitions, Pfizer?November 25, 2009 – The Motley Fool
Novartis Didn't Know JAK, Until NowNovember 25, 2009 – The Motley Fool
4 Platform Drugmakers to Invest InNovember 24, 2009 – The Motley Fool
10 Stocks Shaking the MarketNovember 24, 2009 – The Motley Fool
A Big Upgrade for Allos TherapeuticsNovember 23, 2009 – The Motley Fool
Now's a Great Time to Invest -- So Don't Blow It Like This November 19, 2009 – The Motley Fool
This Stock Is a Train WreckNovember 19, 2009 – The Motley Fool
Drug Lowers Cholesterol; Stock FollowsNovember 18, 2009 – The Motley Fool
The Hottest Sector for 2010November 16, 2009 – The Motley Fool
Abbott: Brave or Stupid?November 13, 2009 – The Motley Fool
5-Star Stocks Poised to Pop: American Oriental BioengineeringNovember 13, 2009 – The Motley Fool
Do You Have the Guts to Buy? November 12, 2009 – The Motley Fool
This Top Stock Is a WinnerNovember 05, 2009 – The Motley Fool
Amylin Scores a Hat TrickNovember 03, 2009 – The Motley Fool
10 Stocks Shaking the MarketNovember 03, 2009 – The Motley Fool
This Just In: Upgrades and DowngradesNovember 03, 2009 – The Motley Fool
Finally Convinced? Benlysta Works!November 02, 2009 – The Motley Fool
Winners and Losers of the House Health-Care Reform BillNovember 02, 2009 – The Motley Fool